Email not displaying correctly? View it in your browser.
|
Meet our plenary and keynote speakers
The congress will feature five pleanary lectures. World leaders in their respective fields will present the keynote lectures for each of the symposia.
|
|
|
Trade, exhibition & sponsorship
An excellent platform for industry and academia to meet. Reach out to leading European biotechnologists through many opportunities available, including:
Showcasing your products/services at the trade exhibition, sponsorship of the congress or individual symposia, taking part in discussions and networking plus more.
|
Register and submit your abstract now!
You can now submit your abstract not only for the ECB2020/IBS2020 6 Streams, but also for,
AFOB/EFB nanobiotechnology highlight event
Choose topic: “Nanobiotechnology” upon submission
ACIB symposium
Choose topic: “Industrial biotechnology; biochemical engineering” upon submission
EuropaBio/EFB highlight event
Choose topic: “General biotechnology” upon submission
AFOB/EFB satellite meeting on biocatalysis
Choose topic: “Biocatalysis and recombinant protein production” upon submission
AFOB/EFB satellite meeting on bioeconomy
Choose topic: “Circular bioeconomy” upon submission.
Deadline for Congress abstract submission:
6 April 2020
|
|
|
|
|
This meeting is a “must attend” event in the field. It is aimed at covering both fundamental and applied aspects related to microbial responses to stress, from molecular to population and system level.
The Scientific Programme enjoys a panel of outstanding speakers and is designed to offer plenty of opportunities not only to established scientists to speak, but also to Early Career Investigators to present their work orally and as posters and to widen their scientific network.
|
|
ASBE V will explore the wealth of applied Synthetic Biology research, covering several bioproducts and application areas by discussing different biological systems——from bacteria through yeast to mammalian cells.
Save the dates and share your research with the global SynBio community!
Early bird registration opening soon.
|
EFB Journal New BiotechnologyDiverse human VH antibody fragments with bio-therapeutic properties from the Crescendo MouseThe Crescendo Mouse produces human VH fragments, or Humabody® VH, with excellent bio-therapeutic potential, as exemplified here by the generation of antagonistic Humabody® VH specific for human IL17A and IL17RA.
|
EFB Polymer Biotechnology Section EventOxiZymes
The purpose of the meeting is to stimulate scientific research on the discovery and mode of action of oxidoreductases and their industrial applications. Initially specifically devoted to research activities on laccases and peroxidases, this series of conferences is now open to contributions related to the whole class of oxidoreductases.
|
EppendorfSciVario® twin – One for All
Scientists need a bioprocess control system that evolves together with their laboratory. With the first bioprocess controller that comes with VisioNize®-onboard and modular hardware features, Eppendorf offers an innovative, intuitive, and intelligent twin-system, ready to bring the digital age to bioprocess laboratories. The SciVario® twin bioprocess controller was launched successfully in February. At launch it supports glass and single-use bioreactors in a range of 0.7 – 3.8 L and can run microbial as well as cell culture applications. With future updates, provided for free by Eppendorf, the SciVario twin will be able to control up to 50 L vessels without the need of any hardware modifications.
|
FEBS Event2020 Advanced Courses
As one of the largest scientific organizations in the European community, and with the general aim of advancement of research and education for the public benefit in the sciences of biochemistry, molecular biology and related disciplines, FEBS funds a range of scientific and educational events on advanced topics in these areas. FEBS funding of courses is focused on promotion of molecular life sciences in Europe and enhancing collaboration between different regions.
|
SCI EventSir Gregory Winter –The antibody revolution, its origin, propagation and impact on the pharmaceutical industry
In recent years the application of genetic engineering technologies and/or laboratory-based evolution have led to the development of antibodies as a new class of pharmaceutical drugs.
Sir Winter will discuss the way in which this technology originated and was propagated, the impact of start-up companies and licensing strategies on the development of this market and on pharmaceutical companies, and the potential for further improvements.
|
|
Prizes include a VIP safari tour, guided tour of the Houses of Parliament, London Symphony Orchestra concert tickets, behind the scenes viewing of the ITV news, a hands-on beekeeping course …and many more! Be in with the chance of winning whilst supporting the biosciences community: enter online at rsb.org.uk/raffle by 25th February 2020.
|
EFB Events
Microbial Stress 2020
organised by EFB Microbial Physiology Section
31 August - 2 September 2020
Rome - Italy
Circular Bioeconomy Summit
organised by EFB Environmental Biotechnology Section in collaboration with Bioeconomy Task Group
Spring 2021
Poland
|
|
|
|
European Federation of Biotechnology
Parc Cientific Barcelona
Baldiri Reixac 4-8
08028 Barcelona, Spain
|
|
|
|
|
|
|
